Company profilePharmaceutical#1223 of 1,318 in Pakistan✓ No DRAP alerts

Pharmaix

Pharmaceutical company · 1 brands · 2 molecules

Ranked #31 of 35 companies in Fever/Flu/Cough

1 registered products 2 pharmaceutical brands 2 distinct molecules 0 DRAP alerts

Company overview

1
registered products
2
pharmaceutical brands
2
distinct molecules
1
therapeutic classes
0
DRAP alerts

Pharmaix is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 1 product registration across 2 distinct molecules. Its portfolio is concentrated in Fever/Flu/Cough. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by Pharmaix

1 product matched in our catalogue — each with its observed price and DRAP approved ceiling.

Top molecules by brand count

Therapeutic classes

Fever/Flu/Cough · 1

Conditions treated

Expectorant · 1

Price band (DRAP official ceilings)

Registered products priced by source
Servaid1 products · Rs 124 – Rs 124
Median across source: Rs 124

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

Glaxo Smith Kline Pakistan Ltd holds 37 molecules not in this portfolio
Acyclovir InfAmmonium ChlorideBacitracinBetamethasoneBetamethasone SodiumCaptopril
P.D.H. PHARMACEUTICALS (PVT) LTD. holds 77 molecules not in this portfolio
AmikacinAmoxicillinAmoxicillin BaseAmoxycillinAmoxycillin BaseAmoxycillin Sodium Amoxycillin Base
ZAFA PHARMACEUTICAL LABORATORIES (PVT) LTD. holds 155 molecules not in this portfolio
AlbuterolAmikacinAminophyllineAmlodipineAmlodipine BaseAmmonium Chloride

Get the full profile for Pharmaix

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.